KPV
Half-life
1 hr
Time to Peak
30 min
Steady State
~1 days
Dose Range
200–1500 mcg
Frequency
Daily
Overview
Anti-inflammatory tripeptide derived from the C-terminal end of alpha-melanocyte stimulating hormone (alpha-MSH). Used for gut inflammation, skin conditions, and general anti-inflammatory purposes. Available via subcutaneous injection, oral capsules, and topical formulations. Limited human PK data. Requires reconstitution with BAC water for injectable use.
Mechanism of Action
Inhibits NF-kB inflammatory pathway activation. Derived from alpha-MSH but lacks melanocortin receptor binding — anti-inflammatory without tanning effects.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Oral | 200–1500 mcg | 1 hr | 30 min | Daily, Twice daily |
| Subcutaneous (SubQ) | 200–1000 mcg | 1 hr | 30 min | Daily |
| Topical | 0.5–2 mL | 1 hr | 30 min | Daily, Twice daily |
Storage & Handling
2-8C — Store lyophilized powder refrigerated. Reconstitute with BAC water for injection. Also available as oral capsules and topical cream.
Used in Regimens
1 regimenData Sources
- Peer-reviewed KPV anti-inflammatory tripeptide mechanisms
Related Tools
Track KPV with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.